<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03863392</url>
  </required_header>
  <id_info>
    <org_study_id>test123</org_study_id>
    <nct_id>NCT03863392</nct_id>
  </id_info>
  <brief_title>Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor</brief_title>
  <official_title>Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Induction of labour at term is a common obstetric intervention. Induction of labour is the
      artificial initiation of labour before its spontaneous onset for the purpose of delivery of
      the fetoplacental unit using mechanical or pharmacological methods.

      To determine the effects of oral misoprostol solution compared to vaginal misoprostol in
      induction of labour.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients recruited in the study will be primigravida at term with obstetric or medical
      indication for labour induction. These patients will be either booked attending antenatal
      clinic referred for induction of labour or emergency admissions in labour room.

      A total of 100 women will be randomly selected for the study. I. Women will be given 20 ml
      (20 µg) of misoprostol solution orally every 2 hourly until adequate uterine contractions
      occurred (3 contractions per 10 min lasting 30-40 s).

      II. The induction regimen included application of Vagiprost 25 µg tablet in the posterior
      fornix of the vagina every 4 h (up to 6 doses) after determination of the Bishop score.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 15, 2018</start_date>
  <completion_date type="Anticipated">March 15, 2019</completion_date>
  <primary_completion_date type="Actual">November 29, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>•Induction-delivery time</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Normal Vaginal Delivery</condition>
  <arm_group>
    <arm_group_label>oral</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing induction of labour using misoprostol oral solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vaginal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing induction of labour using vaginal misoprostol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>induction of labor</description>
    <arm_group_label>oral</arm_group_label>
    <arm_group_label>vaginal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primigravida or Primipara

          -  Pregnancy between 36 and 42 weeks of gestation.

          -  A live singleton fetus in cephalic presentation.

          -  No history of uterine surgery.

          -  Clinically adequate pelvis.

          -  Modified Bishop's score &lt;5.

          -  Reactive Non stress test (NST) .

        Exclusion Criteria:

          -  •Known hypersensitivity or contraindications to oral misoprostol (uterine surgery).

               -  Any antenatal medical complications.

               -  A situation requiring LSCS (Maternal or Fetal) e.g:fetal distress

               -  Non-reactive NST.

               -  Patient's refusal to give consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ainshams University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 18, 2019</study_first_submitted>
  <study_first_submitted_qc>March 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>March 2, 2019</last_update_submitted>
  <last_update_submitted_qc>March 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Peter rafik helmy thabet</investigator_full_name>
    <investigator_title>Clinical investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

